Abstract
The tumour microenvironment (TME) plays an important role in tumour survival and growth, but little is known about the degree of preservation between different stromal response patterns found in primary tumours and their metastases. We have previously identified gene expression profiles for two distinct stromal signatures in breast carcinoma of fibroblast (aka DTF) and macrophage (aka CSF1) response and found them to be correlated with clinicopathological features, including outcome. In this study, we compare the DTF fibroblast and CSF1 macrophage stromal response patterns in primary breast and colorectal cancers to their matched lymph node metastases. In both breast and colorectal cancer, there was a significant positive correlation between the CSF1 macrophage signature in the primary tumours and the matched lymph node metastases, as assessed by immunohistochemical markers. No such correlation was observed for the DTF fibroblast signature. A similar result was seen in independent analysis of two published gene expression microarray datasets. The variations of these stromal reaction patterns from the primary to the metastasis shed light on the relationship between the neoplastic cells and the non-neoplastic cells in the TME. The preservation of the CSF1 macrophage response pattern in metastases lends support to targeting the CSF1 pathway in cancer.
MeSH Terms
Adenocarcinoma/metabolism,secondary
Biomarkers, Tumor/metabolism
Breast Neoplasms/genetics,metabolism,pathology
Colorectal Neoplasms/genetics,metabolism,pathology
Female
Fibroblasts/metabolism
Gene Expression Profiling/methods
Gene Expression Regulation, Neoplastic
Humans
Lymphatic Metastasis/genetics,pathology,physiopathology
Macrophage Colony-Stimulating Factor/genetics,metabolism
Neoplasm Proteins/genetics,metabolism
Oligonucleotide Array Sequence Analysis/methods
Stromal Cells/metabolism
Chemicals
Biomarkers, Tumor
Neoplasm Proteins
Macrophage Colony-Stimulating Factor
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Webster Jonathan A
Department of Pathology, Stanford University Medical Center, Stanford, CA, USA.
Beck Andrew H
Sharma Mimansa
Espinosa Inigo
Weigelt Britta
Schreuder Marthe
Montgomery Kelli D
Jensen Kristin C
van de Rijn Matt
West Robert
References (24)
24 references, click to expand
-
Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival.
Int J Oncol. 2000 Sep;17(3):445-51
PMID: 10938382
-
Prognostic value of tumor-associated macrophage count in human bladder cancer.
Int J Urol. 2000 Jul;7(7):263-9
PMID: 10910229
-
No common denominator for breast cancer lymph node metastasis.
Br J Cancer. 2005 Oct 17;93(8):924-32
PMID: 16189523
-
Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
Am J Gastroenterol. 2004 Sep;99(9):1667-74
PMID: 15330899
-
The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients.
Anticancer Res. 2003 Nov-Dec;23(6D):5015-22
PMID: 14981961
-
The fibromatosis signature defines a robust stromal response in breast carcinoma.
Lab Invest. 2008 Jun;88(6):591-601
PMID: 18414401
-
Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer.
Anticancer Res. 2004 Sep-Oct;24(5C):3335-42
PMID: 15515429
-
The macrophage colony-stimulating factor 1 response signature in breast carcinoma.
Clin Cancer Res. 2009 Feb 1;15(3):778-87
PMID: 19188147
-
Estimation of tumor heterogeneity using CGH array data.
BMC Bioinformatics. 2009 Jan 09;10:12
PMID: 19134174
-
Gene expression profiles of primary breast tumors maintained in distant metastases.
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15901-5
PMID: 14665696
-
Friends or foes - bipolar effects of the tumour stroma in cancer.
Nat Rev Cancer. 2004 Nov;4(11):839-49
PMID: 15516957
-
Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis.
Proteomics. 2008 Dec;8(23-24):5038-52
PMID: 19003862
-
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy.
J Exp Med. 2001 Mar 19;193(6):727-40
PMID: 11257139
-
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.
Cell. 2005 May 6;121(3):335-48
PMID: 15882617
-
Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis.
Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):173-7
PMID: 14734466
-
Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.
Breast Cancer Res Treat. 2010 Sep;123(2):397-404
PMID: 19949854
-
A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth.
PLoS One. 2009 Aug 10;4(8):e6562
PMID: 19668347
-
Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.
Cancer Res. 1999 Oct 1;59(19):5002-11
PMID: 10519415
-
Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density.
Oncol Rep. 2005 Aug;14(2):425-31
PMID: 16012726
-
High macrophage infiltration along the tumor front correlates with improved survival in colon cancer.
Clin Cancer Res. 2007 Mar 1;13(5):1472-9
PMID: 17332291
-
Determination of stromal signatures in breast carcinoma.
PLoS Biol. 2005 Jun;3(6):e187
PMID: 15869330
-
Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis.
Cancer. 2004 Mar 15;100(6):1110-22
PMID: 15022276
-
Clinical effects of tumor-associated macrophages and dendritic cells on renal cell carcinoma.
Anticancer Res. 2002 Nov-Dec;22(6C):4281-4
PMID: 12553070
-
Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).
Blood. 2005 Sep 15;106(6):2169-74
PMID: 15933054